首页> 外国专利> Beta-catenin is a strong and independent prognostic factor for cancer

Beta-catenin is a strong and independent prognostic factor for cancer

机译:β-连环蛋白是癌症的强大且独立的预后因素

摘要

Cyclin D1 is one of the targets of &bgr;-catenin in breast cancer cells. Transactivation of &bgr;-catenin correlated significantly with cyclin D1 expression both in eight breast cell lines in vitro and in 123 patient samples. More importantly, high &bgr;-catenin activity significantly correlated with poor prognosis of the patients and is a strong and independent prognostic factor in breast cancer (p0.001). Moreover, by multivariate analyses, the inventors found that activated &bgr;-catenin is a strong prognostic factor which provided additional and independent predictive information on patients survival rate even when other prognostic factors, including lymph node metastasis, tumor size, estrogen receptor and progesterone receptor status, were taken into account (p0.001). This invention demonstrates that &bgr;-catenin is involved in breast cancer formation and/or progression and may serve as a target for breast cancer therapy.
机译:细胞周期蛋白D1是乳腺癌细胞中连环蛋白的靶标之一。在体外和在123例患者样品中,β-catenin的反式激活与cyclin D1的表达显着相关。更重要的是,高-catenin活性与患者预后差显着相关,并且是乳腺癌的强而独立的预后因素(p <0.001)。此外,通过多变量分析,发明人发现活化的-catenin是一个强大的预后因素,即使在其他预后因素包括淋巴结转移,肿瘤大小,雌激素受体和孕激素受体的情况下,它也能提供有关患者存活率的附加且独立的预测信息。状态,被纳入考虑(p <0.001)。本发明证明β-连环蛋白与乳腺癌的形成和/或发展有关,并可作为乳腺癌治疗的靶标。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号